Skip to content

OÜ PharmaNine

Registry code (registrikood) 14915507Private limited company (Osaühing)VAT EE102233801Activity (EMTAK 47731): Ravimite jaemüükActive

Tallinn, Harju County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€5.0M
▲ 5.9% vs 2024
Profit before tax (2025)
€3.4k
Employees, FTE (2025)
8
State taxes paid, last 4 quarters
€80k

Revenue, profit and employees, 2020–2025

€2.6M2020€3.8M2021€4.1M2022€4.4M2023€4.7M2024€5.0M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2020€2,570,723-€163,079-€163,077-€160,5771
2021€3,788,055€153,390€153,392-€7,1851
2022€4,124,646-€7,400-€7,395-€14,5804
2023€4,432,525€47,441€47,456€32,8764
2024€4,730,051€11,926€11,934€44,8104
2025€5,007,328€3,384€3,388€48,1988

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2020€61,192€1,787,864€1,948,441—-€160,577
2021€72,295€1,716,082€1,723,267—-€7,185
2022€366,961€1,869,225€1,883,805—-€14,580
2023€209,243€1,446,325€1,413,449—€32,876
2024€106,693€1,283,155€1,238,345—€44,810
2025€122,904€1,226,620€1,178,422—€48,198

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€2,992€11,013€1,050,9826
2022 Q2€8,925€16,452€997,1636
2022 Q3€17,206€21,648€930,6649
2022 Q4€17,066€21,272€1,083,2279
2023 Q1€20,060€22,372€1,104,6538
2023 Q2€17,469€20,349€1,046,7098
2023 Q3€13,731€19,208€976,26711
2023 Q4€20,120€20,690€1,287,62411
2024 Q1€18,143€24,914€1,205,87511
2024 Q2€14,291€24,210€1,128,01210
2024 Q3€15,343€24,837€1,099,35310
2024 Q4€19,351€26,240€1,257,38815
2025 Q1€25,884€30,872€1,267,39215
2025 Q2€18,968€27,494€1,230,69617
2025 Q3€15,854€26,667€1,182,92019
2025 Q4€20,223€27,787€1,271,96216
2026 Q1€20,903€29,168€1,402,43816
2026 Q2€16,440€29,316€1,257,58518
2026 Q3€22,021€32,925€1,253,51017

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), OÜ PharmaNine reported revenue of €5,007,328.

The company closed the 2025 financial year with a net profit of €3,388.

Revenue increased by 5.9% from €4,730,051 in 2024 to €5,007,328 in 2025.

Revenue grew at a compound annual rate of 14.3% between 2020 and 2025.

Equity accounted for 3.9% of total assets of €1,226,620 at the end of the 2025 reporting period.

With 8 full-time-equivalent employees in 2025, revenue per employee was €625,916.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, OÜ PharmaNine reported €5,185,495 in turnover.

EMTA recorded 17 employees for the quarter ending Q3 2026, compared with 8 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.